Results 151 to 160 of about 166,717 (318)

Respiratory dysbiosis and population-wide temporal dynamics in canine chronic bronchitis and non-inflammatory respiratory disease

open access: gold, 2020
Aaron C. Ericsson   +4 more
openalex   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami   +2 more
wiley   +1 more source

The objective evaluation of obstructive pulmonary diseases with spirometry

open access: yesInternational Journal of COPD, 2016
Sevket Ozkaya,1 Adem Dirican,2 Tibel Tuna3 1Department of Pulmonary Medicine, Faculty of Medicine, Bahçes¸ehir University, Istanbul, 2Department of Pulmonary Medicine, Samsun Medical Park Hospital, 3Department of Pulmonary Medicine, Samsun ...
Özkaya S, Dirican A, Tuna T
doaj  

European Code Against Cancer, 5th edition – tobacco and nicotine containing products, second‐hand smoke, alcohol and cancer

open access: yesMolecular Oncology, Volume 20, Issue 1, Page 6-27, January 2026.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations on tobacco, second‐hand smoke and alcohol listed as recommendations number 1, 2 and 6. Individuals are advised not to smoke or vape, to quit if they do, keep their home and car smoke‐free ...
Ariadna Feliu   +19 more
wiley   +1 more source

Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn

open access: bronze, 2002
Paula Pallasaho   +6 more
openalex   +1 more source

Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics

open access: yesAdvanced Materials, Volume 38, Issue 1, 2 January 2026.
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding   +11 more
wiley   +1 more source

Clinical issues of mucus accumulation in COPD

open access: yesInternational Journal of COPD, 2014
Frederick L Ramos, Jason S Krahnke, Victor KimDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USAAbstract: Airway mucus is part of the lung's native immune function ...
Ramos FL, Krahnke JS, Kim V
doaj  

Real‐World Treatment Patterns in AERD: An Analysis of ATAD, Biologics, and Combination Therapy

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 99-101, January 2026.
Key Points Contemporary aspirin exacerbated respiratory disorder (AERD) therapy commonly includes aspirin desensitization (55%) and biologics (48%). Aspirin desensitization therapy has higher discontinuation rates than biologics. Patients receiving biologics are younger, and ∼25% of the patients switch to other agents.
Nitish Kumar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy